The first samples of the Sputnik V vaccine had arrived in Uzbekistan, where drug’s subsequent industrial production will continue, the Russian Industry and Trade Ministry’s website reported on Friday.
For Uzbekistan, the volume of vaccines produced will soon reach 2 mln doses. On Friday, Denis Manturov, Industry and Trade Minister personally delivered to Uzbekistan samples of the Sputnik V vaccine against corona infection.
Holmamat Norboyev, Deputy Head of the Service for Sanitary and Epidemiological Welfare and Public Health of the Republic of Uzbekistan, has received the valuable cargo.
The first anti-COVID drug samples were submitted to the Uzbek side in order to conduct the trials necessary to obtain registration and launch industrial production of the vaccine in Uzbekistan.
In perspective, the volume of antivirus Sputnik V drugs produced will soon reach 2 mln doses which would allow launching inoculation across the Russian Federation.
Russia’s vaccine Sputnik V became the first world’s anti-COVID drug
On August 11, Russia became the first worldwide to register the vaccine against the coronavirus which was named Sputnik V. The preparation was developed by the Gamaleya National Research Center for Epidemiology and Microbiology of the Russian Healthcare Ministry.
The effectiveness of the Sputnik V vaccine, according to the interim trial results, surpasses 95% on Day 42 after administration of a first dose of the preparation if a patient receives a second dose.
Since August, more than 50 nations have requested the Russian Sputnik V. At least 1.2 bln doses of the vaccine will be sent across the globe, and the process has already started. To curb the corona epidemic, the vaccine for foreign markets will be manufactured by international partners in India, Brazil, China, South Korea, and others.
